These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37781028)

  • 1. Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis.
    Wang X; Chen Q; Bing Z; Zhou S; Xu Z; Hou Y; Zhao Y; Zhao S; Wang T
    Int J Biol Sci; 2023; 19(14):4672-4688. PubMed ID: 37781028
    [No Abstract]   [Full Text] [Related]  

  • 2. YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6.
    Zhou Q; Tian M; Cao Y; Tang M; Xiang X; Guo L; Lv H
    Biol Direct; 2024 Jul; 19(1):54. PubMed ID: 38978074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
    Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y
    Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1.
    Wang D; Guan H; Xia Y
    Biochem Pharmacol; 2023 Apr; 210():115456. PubMed ID: 36780989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mir22hg facilitates ferritinophagy-mediated ferroptosis in sepsis by recruiting the m6A reader YTHDC1 and enhancing Angptl4 mRNA stability.
    Deng W; Zhong L; Ye S; Luo J; Ren G; Huang J; Zhuang X
    J Bioenerg Biomembr; 2024 Aug; 56(4):405-418. PubMed ID: 38842666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development.
    Kasowitz SD; Ma J; Anderson SJ; Leu NA; Xu Y; Gregory BD; Schultz RM; Wang PJ
    PLoS Genet; 2018 May; 14(5):e1007412. PubMed ID: 29799838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
    Cui X; Nilsson K; Kajitani N; Schwartz S
    Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m
    Yang Y; Zhang Y; Chen G; Sun B; Luo F; Gao Y; Feng H; Li Y
    J Exp Clin Cancer Res; 2024 May; 43(1):141. PubMed ID: 38745192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W
    Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Expression of YTH Domain-Containing 1 Promotes Microglial M1 Polarization by Reducing the Stability of Sirtuin 1 mRNA.
    Zhou H; Xu Z; Liao X; Tang S; Li N; Hou S
    Front Cell Neurosci; 2021; 15():774305. PubMed ID: 34975410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR-dependent manner.
    Zhang M; Guan J; Yu S; Zhang Y; Cheng L; Zhang Y
    J Leukoc Biol; 2024 May; 115(6):1154-1164. PubMed ID: 38289832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells.
    Shan M; Liu D; Sun L; Yang M; He M; Zhang Y; Xiang L; Lu L; He H; Niu D; Chen L; Li S; Chen A; He F; Wang Y; Lian J
    Cancer Lett; 2024 Mar; 584():216598. PubMed ID: 38224863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication.
    Sheng Y; Wei J; Yu F; Xu H; Yu C; Wu Q; Liu Y; Li L; Cui XL; Gu X; Shen B; Li W; Huang Y; Bhaduri-McIntosh S; He C; Qian Z
    Blood; 2021 Dec; 138(26):2838-2852. PubMed ID: 34255814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export.
    Qiao Y; Sun Q; Chen X; He L; Wang D; Su R; Xue Y; Sun H; Wang H
    Elife; 2023 Mar; 12():. PubMed ID: 36892464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation.
    Li H; Lin R; Zhang Y; Zhu Y; Huang S; Lan J; Lu N; Xie C; He S; Zhang W
    Mol Cancer; 2024 Jan; 23(1):5. PubMed ID: 38184597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation.
    Lee JH; Wang R; Xiong F; Krakowiak J; Liao Z; Nguyen PT; Moroz-Omori EV; Shao J; Zhu X; Bolt MJ; Wu H; Singh PK; Bi M; Shi CJ; Jamal N; Li G; Mistry R; Jung SY; Tsai KL; Ferreon JC; Stossi F; Caflisch A; Liu Z; Mancini MA; Li W
    Mol Cell; 2021 Aug; 81(16):3368-3385.e9. PubMed ID: 34375583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
    Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
    Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.
    Li W; Ye K; Li X; Liu X; Peng M; Chen F; Xiong W; Wang Y; Zhu L
    J Exp Clin Cancer Res; 2022 Aug; 41(1):250. PubMed ID: 35974388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer.
    Shen X; Zhong J; Yu P; Liu F; Peng H; Chen N
    Cancer Sci; 2024 Jun; 115(6):1881-1895. PubMed ID: 38566554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway.
    Cao D; Ge S; Li M
    J Bone Oncol; 2022 Apr; 33():100412. PubMed ID: 35198364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.